Transcranial magnetic stimulation for migraine: Clinical effects

被引：81

作者：

Clarke B.M. ^{[1
,2
]}

Upton A.R.M. ^{[1
]}

Kamath M.V. ^{[1
]}

Al-Harbi T. ^{[1
]}

Castellanos C.M. ^{[1
]}

机构：

[1] Division of Neurology, McMaster University, Hamilton, ON L8N 3Z5

[2] Hamilton Health Sciences Centre, Department of Clinical Neurology, McMaster University, Hamilton, ON L8N 3Z5

来源：

The Journal of Headache and Pain | 2006年 / 7卷 / 5期

基金：

加拿大自然科学与工程研究理事会;

关键词：

Migraine; Pain; Transcranial magnetic stimulation;

D O I：

10.1007/s10194-006-0329-8

中图分类号：

学科分类号：

摘要：

The objective was to assess the impact of transcranial magnetic stimulation (TMS) on pain and the autonomic nervous system (ANS) in migraine. Fortytwo people [mean age 41.43 ± 11.69 (SD) years, 36 females] were randomised into high vs. low TMS stimulation groups and received 2 brief pulses of TMS. Thirty-three (33/42) individuals had heart-rate variability assessed, before and after stimulation. No group effects were found. Pain decreased by 75%; 32% of people after 1 treatment reported no headache after 24 h. Mean heart rate decreased from 79.05 ± 10.27 to 72.89 ± 11.35 beats/min. The low-frequency (LF) and the high-frequency (HF) areas derived from power spectral analyses increased [mean 6522 ± 1277 to 8315 ± 1009 beats/min2 (LF) (p=0.001) and mean 5600 ± 1568 to 8755 ± 3071 beats/min2 (HF) (p=0.001)]. The LF:HF ratio decreased from mean 1.31 ± 0.51 to 1.13 ± 0.48 (NS). TMS produces immediate, sustained reductions in pain and modification of the ANS. © Springer-Verlag Italia 2006.

引用

页码：341 / 346

页数：5

共 42 条

[1]

Gallagher R.M., What do patients want from acute migraine treatment?, Cephalalgia, 24, SUPPL. 4, pp. 8-15, (2004)

[2]

Massiou H., Migraine medication attributes are important for patient compliance, Drugs Today, 39, SUPPL. D, pp. 25-29, (2003)

[3]

Leonardi M., Steiner T.J., Scher A.T., Lipton R.B., The global burden of migraine: Measuring, disability in headache disorders with WHO's classification of functioning, disability and health (ICF), J Headache Pain, 6, pp. 429-440, (2005)

[4]

Montagna P., Cortelli P., Barbiroli B., Magnetic-resonance spectroscopy studies in migraine, Cephalalgia, 14, pp. 184-193, (1994)

[5]

Schoenen J., Thomsen L.L., Neurophysiology and autonomic dysfunction in migraine, The Headache, (2000)

[6]

Shechter A., Stewart W.F., Silberstein S.D., Lipton R.B., Migraine and autonomic nervous system function - A population-based, case-control study, Neurology, 58, pp. 422-427, (2002)

[7]

Welch K.M.A., Barkley G.L., Tepley N., Ramadan N.M., Central neurogenic mechanisms of migraine, Neurology, 43, SUPPL. 3, (1993)

[8]

Fumal A., Bohotin V., Vandenheede M., Schoenen J., Transcranial magnetic stimulation in migraine: A review of facts and controversies, Acta Neurol Belg, 103, pp. 144-154, (2003)

[9]

Aurora S.K., Welch K.M.A., Brain excitability in migraine: Evidence from transcranial magnetic stimulation studies, Curr Opin Neurol, 11, pp. 205-209, (1998)

[10]

Aurora S.K., Ahmad B.K., Welch K.M.A., Et al., Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine, Neurology, 50, pp. 1111-1114, (1998)

← 1 2 3 4 5 →